IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
NEJM -- Chronic Myeloid Leukemia -- Advances in Biology and New Approaches to Treatment -- Figure 2
The Capable ABL: What Is Its Biological Function? | Molecular and Cellular Biology
c‑Abl‑mediated tyrosine phosphorylation of DNA damage response proteins and implications in important cellular functions (Review)
Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein | Haematologica
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
The Capable ABL: What Is Its Biological Function? | Molecular and Cellular Biology
BCR ABL Protein - an overview | ScienceDirect Topics
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation
Abl Oncogenes (Molecular Biology)
BCR/ABL inhibition by an escort/phosphatase fusion protein | PNAS
Is the fusion Bcr-Abl protein the same thing as Abl kinase? - The Student Room
IJMS | Free Full-Text | c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
BCR-ABL fusion protein
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
PF‑114, a novel selective inhibitor of BCR‑ABL tyrosine kinase, is a potent inducer of apoptosis in chronic myelogenous leukemia cells